Zoetis Inc header image

Zoetis Inc

ZTS

Equity

ISIN null / Valor 19276994

New York Stock Exchange, Inc (2026-10-08)
USD 73.08+2.14%

Zoetis Inc
UMushroom community rating:

star star star star star
3.57 5 votes No rating yet
NegativeNeutralPositive

About company

Zoetis Inc. is a global leader in the animal health industry, providing a comprehensive range of products and services that cater to the health needs of animals. With operations spanning over 100 countries, the company's portfolio encompasses a wide array of medicines, vaccines, diagnostics, and technologies designed to support the health and well-being of animals across various sectors, including livestock and companion animals. Zoetis is recognized for its innovative approach in developing solutions that address both common and emerging health challenges faced by animals, thereby contributing significantly to the global animal health sector. The company's commitment to research and development is evident in its robust pipeline, which ensures a continuous introduction of new and improved products to the market, further solidifying its position as a key player in the animal health industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-49.1%1Y
-58.4%3Y
-63.1%5Y

Performance

39.7%1Y
31.2%3Y
30.1%5Y

Volatility

Market cap

30198 M

Market cap (USD)

Daily traded volume (Shares)

6,176,470

Daily traded volume (Shares)

1 day high/low

163.89 / 161.59

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.57

5 votes
Performance:
starstarstarstarstar
3.71
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Noah Juganar
UK, 23 Oct 2025
star star star star star
Solid fundamentals in financials & competitive advantages
D X
Switzerland, 16 Apr 2025
star star star star star
Langfristige Chance
D X
Switzerland, 29 Mar 2025
star star star star star
Ein Unternehmen, das meiner Meinung nach in einem zukunftsträchtigen Markt vorne mit dabei ist.

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
17.46%USD 119.47
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%USD 105.96
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.01%USD 28.06
Harrow Inc
Harrow Inc Harrow Inc Valor: 45675535
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%USD 30.52
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.14%USD 94.32
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.37%USD 387.12
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 16.37
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 7.96
Geratherm Medical AG
Geratherm Medical AG Geratherm Medical AG Valor: 1091371
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.74%EUR 1.98
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 34.83